News

Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited ...
EurekAlert!1d
Breakthrough study identifies promising biomarker for early sepsis detection in neonates, children, and pregnant women
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...
Oklahoma City bombing trauma changed the ‘actual physical being’ of survivors
Psychological trauma can unfortunately linger for years. However, according to recent research, it may even remain in the ...
Dermatology Advisor3d
Icotrokinra for Plaque Psoriasis Superior to Placebo for Skin Clearance, Safety
Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.
News-Medical.Net3d
IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, ...
MPR5d
FDA Drug Approval Decisions Expected in May 2025
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Medindia5d
The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
(HKEX: 02162)�("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed�IL-4Ra ...